Financial Performance - The company's revenue for Q1 2025 was CNY 625,145,364.48, representing a 20.35% increase compared to CNY 519,450,050.36 in the same period last year[4]. - Net profit attributable to shareholders was CNY 51,116,537.85, up 13.23% from CNY 45,143,153.81 year-on-year[4]. - Basic and diluted earnings per share increased by 14.53% to CNY 0.0662, compared to CNY 0.0578 in the same period last year[4]. - Net profit for the current period was ¥51,782,589.64, representing a 9.3% increase from ¥47,574,039.07 in the previous period[23]. - Earnings per share (EPS) for the current period was ¥0.0662, compared to ¥0.0578 in the previous period, reflecting a growth of 14.9%[23]. - The company reported a total comprehensive income of ¥50,939,813.63 for the current period, compared to ¥46,785,956.65 in the previous period, an increase of 8.6%[23]. Cash Flow - The net cash flow from operating activities decreased by 21.22% to CNY 57,819,950.74, down from CNY 73,390,050.46 in the previous year[4]. - Operating cash flow for the current period is ¥57,819,950.74, a decrease of 21.2% from ¥73,390,050.46 in the previous period[24]. - Total cash inflow from operating activities is ¥593,282,261.11, compared to ¥571,501,441.52 in the previous period, reflecting a growth of 3.1%[24]. - Cash outflow from operating activities increased to ¥535,462,310.37 from ¥498,111,391.06, representing a rise of 7.5%[24]. - Investment activities generated a net cash flow of -¥67,865,040.40, an improvement from -¥83,274,179.55 in the previous period[24]. - Net cash flow from financing activities decreased by CNY 105,384,328.70, a decline of 95.27%, as operating cash flow was sufficient to meet the company's normal operational needs, reducing bank borrowings[13]. - Net cash flow from financing activities was ¥5,230,846.58, significantly lower than ¥110,615,175.28 in the previous period, a decline of 95.3%[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 5,682,049,224.10, a slight increase of 0.56% from CNY 5,650,587,583.04 at the end of the previous year[4]. - Total assets as of the end of the current period were ¥5,682,049,224.10, slightly up from ¥5,650,587,583.04 in the previous period[21]. - Total liabilities decreased to ¥3,123,997,855.14 from ¥3,150,724,813.22, indicating a reduction of 0.8%[21]. - The total equity attributable to shareholders of the parent company increased to ¥2,303,056,809.68 from ¥2,246,607,845.93, marking a growth of 2.5%[21]. Expenses - Total operating costs amounted to ¥569,770,727.13, up 21.3% from ¥469,749,153.26 in the prior period[22]. - Management expenses increased by 49.28% to CNY 25,664,246.52, mainly due to salary adjustments and legal fees for tax refund assistance[7]. - Research and development expenses for the current period were ¥22,598,102.58, up from ¥19,538,556.28, reflecting an increase of 10.5%[22]. Investments - Investment income rose by 118.04% to CNY 571,820.19, mainly from interest on debt investments by a subsidiary[8]. - The company reported a decrease in long-term equity investments to CNY 259,204.80 from CNY 259,573.12, suggesting stability in investment holdings[19]. - The company received ¥1,200,000.00 from minority shareholders as part of investment activities[24]. - Cash received from other financing activities increased to ¥63,184,715.90 from ¥50,000,000.00, a growth of 26.4%[25]. Shareholder Information - Total number of common shareholders at the end of the reporting period was 31,569, with no preferred shareholders[15]. - The largest shareholder, Inner Mongolia Jinhe Holdings Co., Ltd., holds 31.33% of shares, totaling 241,758,670 shares[15]. Inventory and Receivables - Accounts receivable increased to CNY 543,379,584.90 from CNY 498,611,653.92, indicating a rise in credit sales[19]. - Inventory at the end of the reporting period was CNY 666,182,132.79, up from CNY 635,279,943.82, reflecting increased stock levels[19]. Other Financial Metrics - The company reported a significant increase in prepayments, which rose by 159.60% to CNY 28,284,968.40, primarily to ensure sufficient supply of raw materials[6]. - The company experienced a 60.92% increase in taxes and surcharges, amounting to CNY 2,227,076.54, attributed to improved operational performance[7]. - The company reported a 51.13% decrease in tax refunds received, totaling CNY 15,891,497.15, due to the absence of customs duty refunds this period[11]. - Deferred income tax assets decreased to ¥51,963,930.59 from ¥71,211,031.61, a decline of 26.9%[20]. Audit Information - The company did not undergo an audit for the first quarter report[26].

截至4月24日收盘，宠物经济概念上涨1.74%，位居概念板块涨幅第4，板块内，49股上涨，天元宠物 20%涨停，中宠股份、依依股份等涨停，乖宝宠物、路斯股份、科拓生物等涨幅居前，分别上涨 15.44%、14.74%、11.58%。跌幅居前的有海能技术、海昇药业、祖名股份等，分别下跌5.87%、 4.97%、3.56%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | PEEK材料 | 3.70 | 电子身份证 | -3.20 | | 丙烯酸 | 1.89 | 华为盘古 | -3.13 | | 天津自贸区 | 1.75 | 数字货币 | -3.10 | | 宠物经济 | 1.74 | 数据安全 | -3.07 | | 维生素 | 1.35 | 云办公 | -2.98 | | 阿尔茨海默概念 | 1.30 | 智谱AI | -2.98 | | NMN概念 | 1.22 | 数据确权 | -2.94 | | 人造肉 | 1.06 | 智慧政务 | -2.92 | | CRO概念 | 0.96 | 华为鲲鹏 | -2 ...

Investment Rating - The report maintains a "Recommended" investment rating for the industry, suggesting a potential upside of over 15% relative to benchmark indices [4]. Core Insights - The swine industry shows stable breeding profits, with a focus on capacity reduction logic. The average price of external three yuan pigs was 15.0 CNY/kg, up 2.1% week-on-week, while the average weight of pigs sold was 128.6 kg, down 0.2% [19][20]. - The beef industry is at an inflection point, with strong price performance continuing. The average price of calves was 28.2 CNY/kg, up 2.1%, and the average price of fattened cattle was 25.8 CNY/kg, up 0.7% [23][30]. - The white chicken market is affected by ongoing avian influenza, with significant impacts on breeding stock and prices. The average price of white feather broiler chicks was 2.8 CNY/chick, up 9.5% [31][34]. - The animal health sector is seeing a recovery in demand as breeding supply stabilizes, with a notable increase in the issuance of vaccines [48][49]. Summary by Sections Swine Industry - The average price of external three yuan pigs was 15.0 CNY/kg, reflecting a week-on-week increase of 2.1%. The average weight of pigs sold was 128.6 kg, down 0.2%. The price of 15 kg external three yuan piglets was 668 CNY/head, with a slight decrease of 0.05% [19][21]. - Supply pressure remains stable, with normal sales rhythms from large producers and limited sales from smallholders. The demand side shows increased activity from secondary breeding, but overall consumption remains weak [20][21]. - The report recommends companies such as Muyuan Foods, Wens Foodstuff Group, and New Hope Liuhe for investment [20]. Beef Industry - The beef breeding industry is entering a capacity release phase, with the earliest signs of a price bottom forming. The report anticipates a potential recovery in the industry by late 2025 or early 2026 [23][30]. - The average wholesale price of beef was 61.4 CNY/kg, reflecting a slight increase of 0.2% [29][30]. - Recommended companies include Fucheng Co. and Guangming Meat Industry, focusing on integrated breeding and sales [23]. Poultry Industry - The average price of white feather broiler eggs was 1.6 CNY/egg, up 2.0%, while the average price of white feather broilers was 3.7 CNY/kg, up 2.2% [31][34]. - The report highlights the impact of avian influenza on breeding imports, particularly from the U.S. and New Zealand, which has been suspended for over three months [31][32]. - Recommended companies include Yisheng Livestock and He Feng Food [31]. Animal Health Sector - The demand for animal health products is expected to recover as breeding supply stabilizes. The issuance of vaccines has shown significant increases, particularly for swine diseases [48][49]. - The report recommends companies like Kexin Biological and Zhongmu Biotechnology, which are positioned to benefit from the recovery in the animal health market [49].

证券代码：002688 证券简称：金河生物 公告编号：2025-015 金河生物科技股份有限公司 第六届董事会第二十四次会议决议公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚假记载、误导性陈述或者重 大遗漏承担责任。 金河生物科技股份有限公司（以下简称"公司"）第六届董事会第二十四次会议于2025年4月9日以电子邮 件方式发出通知，并于2025年4月18日以通讯方式召开，会议由董事长王东晓先生主持，应到董事9人， 实到董事9人，本次董事会出席会议董事人数符合法律法规，会议合法有效。会议召开符合《中华人民 共和国公司法》等法律、法规和《公司章程》的规定。与会董事以通讯表决的方式审议通过了以下议 案： 一、以9票同意，0票反对，0票弃权审议通过了《关于变更公司注册资本及修订〈公司章程〉部分条款 的议案》。 本议案需提交2025年第二次临时股东大会审议。 具体内容详见公司同日于巨潮资讯网（http://www.cninfo.com.cn）及《证券时报》、《中国证券报》、 《证券日报》和《上海证券报》披露的《关于变更公司注册资本及修订〈公司章程〉部分条款的公 告》，修订后的《公司章程》详见巨 ...

金河生物科技股份有限公司（以下简称"公司"）于 2025 年 4 月 18 日召开 第六届董事会第二十四次会议，审议通过了《关于变更公司注册资本及修订<公 司章程>部分条款的议案》。现将具体情况公告如下： 一、修订《公司章程》和注册资本变更说明 证券代码：002688 证券简称：金河生物 公告编号：2025-016 金河生物科技股份有限公司 关于变更公司注册资本及修订《公司章程》部分条款的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 除上述条款修订外，《公司章程》其他内容不变，本议案尚需提交公司股东 大会审议，公司董事会提请股东大会授权公司管理层或其授权代表办理工商变更 登记、备案等事宜，具体变更内容以工商登记机关核准的内容为准。修订后的《公 司章程》全文详见巨潮资讯网。 鉴于公司第六届董事会第十八次会议、第六届监事会第十五次会议及 2024 年第二次临时股东大会分别审议通过了《关于回购注销部分限制性股票的议案》。 公司 2023 年限制性股票激励计划首次授予激励对象中 1 人因退休离职，已不符 合激励对象条件，公司拟回购注销激励对象已获授 ...

证券代码：002688 证券简称：金河生物 公告编号：2025-017 金河生物科技股份有限公司 关于召开 2025 年第二次临时股东大会通知的公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 一、召开会议的基本情况 1、股东大会届次：2025 年第二次临时股东大会 2、会议召集人：金河生物科技股份有限公司（以下简称"公司"）董事 会 3、会议召开的合法、合规性：公司于 2025 年 4 月 18 日召开了第六届董 事会第二十四次会议，会议决定于 2025 年 5 月 6 日召开公司 2025 年第二次临 时股东大会。本次股东大会的召开符合有关法律、行政法规、部门规章、规范 性文件和《公司章程》等的规定。 4、会议召开的日期、时间： （1）现场会议召开时间：2025 年 5 月 6 日下午 14:30 （2）网络投票时间：2025 年 5 月 6 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 6 日的交易时间，即 9:15-9:25，9:30-11:30 和 13:00-15:00；通过深圳证 券交易所互联 ...

本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 证券代码：002688 证券简称：金河生物 公告编号：2025-015 金河生物科技股份有限公司 第六届董事会第二十四次会议决议公告 金河生物科技股份有限公司（以下简称"公司"）第六届董事会第二十四次 会议于 2025 年 4 月 9 日以电子邮件方式发出通知，并于 2025 年 4 月 18 日以通 讯方式召开，会议由董事长王东晓先生主持，应到董事 9 人，实到董事 9 人，本 次董事会出席会议董事人数符合法律法规，会议合法有效。会议召开符合《中华 人民共和国公司法》等法律、法规和《公司章程》的规定。与会董事以通讯表决 的方式审议通过了以下议案： 一、以 9 票同意，0 票反对，0 票弃权审议通过了《关于变更公司注册资本 及修订<公司章程>部分条款的议案》。 本议案需提交 2025 年第二次临时股东大会审议。 具体内容详见公司同日于巨潮资讯网（http://www.cninfo.com.cn）及《证 券时报》、《中国证券报》、《证券日报》和《上海证券报》披露的《关于变更 公司注册资本及修订<公司章程 ...

金河生物科技股份有限公司章程 金河生物科技股份有限公司 章 程 （二〇二五年四月修订） | 第一章 总则 3 | | --- | | 第二章 经营宗旨和范围 4 | | 第三章 股份 4 | | 第一节 股份发行 4 | | 第二节 股份增减和回购 7 | | 第三节 股份转让 8 | | 第四章 股东和股东大会 9 | | 第一节 股东 9 | | 第二节 股东大会的一般规定 11 | | 第三节 股东大会的召集 14 | | 第四节 股东大会的提案与通知 15 | | 第五节 股东大会的召开 17 | | 第六节 股东大会的表决和决议 19 | | 第五章 董事会 24 | | 第一节 董事 24 | | 第二节 董事会 27 | | 第六章 总经理及其他高级管理人员 31 | | 第七章 监事会 32 | | 第一节 监事 32 | | 第二节 监事会 33 | | 第八章 财务会计制度、利润分配和审计 34 | | 第一节 财务会计制度 34 | | 第二节 内部审计 37 | | 第三节 会计师事务所的聘任 37 | | 第九章 通知和公告 38 | | 第一节 通知 38 | | 第二节 公告 3 ...

这几只票暗盘资金正在偷偷流入，立即查看>> 养殖业板块震荡走低，金河生物（002688）跌超9%，晓鸣股份（300967）、回盛生物（300871）、华 英农业（002321）、罗牛山（000735）、神农集团（605296）等跟跌。 ...

深交所公开信息显示，当日该股因日跌幅偏离值达-8.47%上榜，营业部席位合计净卖出4394.91万元。 金河生物今日下跌7.32%，全天换手率27.70%，成交额14.52亿元，振幅8.27%。龙虎榜数据显示，营业 部席位合计净卖出4394.91万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交2.22亿元，其中，买入成交额为8908.12 万元，卖出成交额为1.33亿元，合计净卖出4394.91万元。 具体来看，今日上榜营业部中，第一大买入营业部为东方财富证券股份有限公司拉萨东环路第二证券营 业部，买入金额为2119.44万元，第一大卖出营业部为中国银河证券股份有限公司成都益州大道证券营 业部，卖出金额为3067.74万元。 近半年该股累计上榜龙虎榜5次，上榜次日股价平均涨0.64%，上榜后5日平均涨3.36%。 卖五 平安证券股份有限公司四川分公司 281.43 1483.75 （文章来源：证券时报网） 资金流向方面，今日该股主力资金净流出6037.10万元，其中，特大单净流出984.63万元，大单资金净流 出5052.47万元。近5日主力资金净流出7.80亿元。（数据宝） 金河生物4月14 ...